Probe-based confocal laser endomicroscopy versus biopsies in the diagnostics of oesophageal and gastric lesions: A prospective, pathologist-blinded study

Marek Kollar, Jana Krajciova, Lucia Prefertusova, Eva Sticova, Jana Maluskova, Zuzana Vackova, Jan Martinek, Marek Kollar, Jana Krajciova, Lucia Prefertusova, Eva Sticova, Jana Maluskova, Zuzana Vackova, Jan Martinek

Abstract

Background and aim: Probe-based confocal laser endomicroscopy (pCLE) provides real-time microscopic visualisation. Our aim was to compare the diagnostic accuracy of pCLE with standard biopsies in patients with visible oesophageal or gastric lesions.

Methods: This was a single-centre, prospective, pathologist-blinded study. Patients underwent high-resolution endoscopy, and lesions were examined by pCLE followed by standard biopsies. A definitive diagnosis was determined from resection specimen. Main outcomes were overall diagnostic accuracy, sensitivity, specificity and positive and negative predictive values.

Results: We examined 74 lesions in 67 patients. Definitive diagnoses revealed 34 malignant and 40 non-malignant lesions. pCLE diagnosis was correct in 89.2% (66/74), while diagnosis based on biopsy was correct in 85% (57/67; p = 0.6). The overall diagnostic accuracy of biopsies was 85% (76-94%) and that of pCLE was 89% (79-96%). pCLE correctly diagnosed malignant lesions, comprising oesophageal adenocarcinoma, oesophageal squamous-cell cancer or gastric adenocarcinoma, in 88.2% (30/34) of cases, while biopsy was correctly diagnosed in 75.9% (22/29; p = 0.3). Sensitivity and specificity to diagnose a malignant lesion were 75.9% (95% confidence interval (CI) 56-89%) and 100% (95% CI 90-100%) for biopsies and 88.2% (95% CI 72-97%) and 92% (95% CI 79-98%) for pCLE. No differences between biopsies and pCLE were found with regard to sensitivity, specificity to diagnose dysplastic and benign lesions (p > 0.2).

Conclusion: pCLE provides satisfactory diagnostic accuracy comparable with standard biopsies in patients with oesophageal or gastric lesions. ClinicalTrials.gov identifier: NCT0292049).

Trial registration: ClinicalTrials.gov NCT02922049.

Keywords: Confocal laser endomicroscopy; oesophageal and gastric cancer.

Figures

Figure 1.
Figure 1.
Granular cell tumour, Abrikossoff’s tumour (left: endoscopy with the lesion; middle: standard histopathology; right: pCLE). Correct diagnosis was made by both pCLE and histology. pCLE: probe-based confocal laser endomicroscopy.
Figure 2.
Figure 2.
Agreement in the diagnosis in a patient with Barrett’s oesophagus (left: high-grade dysplasia (HGD), standard histopathology; right: HGD, pCLE). 1. Unequal luminal surface in dysplastic gland. 2. High activity of dysplastic cells (left: nucleocytoplasmic ratio increased; right: dark cells).
Figure 3.
Figure 3.
Agreement in the diagnosis (left: standard histopathology; right: pCLE). 1. Serrated hyperplastic gastric epithelium with low-grade dysplasia; right: unequal epithelium structures of the serrated adenoma.
Figure 4.
Figure 4.
Incorrect diagnosis by pCLE (left: gastritis, standard histopathology; right: dysplastic appearance, pCLE); correct diagnosis was gastritis. 1. Unequal luminal surface in dysplastic gland. 2. High activity of cells influenced by inflammation (left: nucleocytoplasmic ratio increased; right: dark cells).

Source: PubMed

3
구독하다